Breast health concerns often go unnoticed—until they become complex.

Clinical guidelines emphasize the importance of earlier screening:

Many healthcare providers recommend starting breast health checks in your mid-20s. If you have dense breast tissue, your risk may be higher, and extra screening options can help provide a more complete picture.

BreastHealth.ai makes it easy to integrate breast health checks into routine care.

• Clinically validated, quick, and affordable

• Non-invasive, radiation-free, and pain-free

• Suitable for all ages and breast densities

✔️ Easy to roll out and scale
✔️ Excellent ROI
✔️ No certified technician required (we offer free training)
✔️ Minimal footprint
✔️ Portable (fits in a backpack)
✔️ Low capex & Minimal opex
✔️ Bring another source of revenue stream to your practice

Why healthcare providers choose BreastHealth.ai ?

BreastHealth.ai integrates seamlessly into your existing wellness or clinical workflow with no disruption to operations, and provide complete peace of mind for your patients.

Publications

BMJ Open Journal

Multicentric study to evaluate the effectiveness of Thermalytix as compared with standard screening modalities in subjects who show possible symptoms of suspected breast cancer.

ASCO JCO Journal

Observational study on the clinical efficacy of Thermalytix for detecting breast cancer in symptomatic and asymptomatic women, published in the Journal of Clinical Oncology Global Oncology.

Frontiers in AI Journal

International Journal Of Community Medicine

Prospective evaluation of breast thermography enhanced by a novel machine learning technique for screening breast abnormalities in women at a secondary care hospital, published in Frontiers.

Feasibility and outcomes of using a novel artificial intelligence enhanced breast thermography technique, Thermalytix, in screening for breast abnormalities at primary health centres at the community level in South India

Lancet Oncology

Performance of artificial intelligence-based breast cancer screening in a community setting: a real-world evaluation study. The Lancet Oncology. 2022 Jul 1;23:S20

An Automated Risk Stratification System for Breast Cancer Screening using Thermalytix. Cancer Research. 2023 Mar 1;and San Antonio Breast Cancer Symposium Dec 2022:P3-03

SABCS 2022

Results of multiple clinical studies comparing Niramai's technology with current standard of care have been published in peer reviewed conference/journals. Some clinical studies and real world evaluations published in top peer reviewed journal publications are listed below.

Access the full list of Peer-Reviewed Publications below:

We are currently deploying Breasthealth.ai's technology across Europe - join us to bring a new source of revenue to your practice!